关键信息
-
基因名
NaCT
- 应用
-
别名
NACT
-
种属
Human
-
表达系统
Baculovirus
-
标签
Tag Free
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q86YT5-1
-
表达区间
M1-T568
-
蛋白长度
Full Length of Isoform-1
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
NaCT (N-acetyltransferase) is a key enzyme involved in the metabolism of various substances, including drugs and endogenous compounds. Its primary function is to catalyze the transfer of an acetyl group from acetyl-CoA to various amines, which can influence the pharmacokinetics and toxicity of many pharmacological agents. The study of NaCT has gained significant attention due to its implications in drug metabolism, therapeutic efficacy, and individual variability in drug response. Recent advances in recombinant protein technology have enabled researchers to produce purified NaCT for in vitro studies, facilitating the elucidation of its structure, function, and interactions with other biomolecules. Understanding NaCT's role may provide insights into its potential as a therapeutic target and its involvement in diseases linked to altered drug metabolism, such as cancer and metabolic disorders. Additionally, the development of specific inhibitors or activators of NaCT could enhance drug safety profiles and personalized medicine approaches. The ongoing research on NaCT aims to uncover its detailed mechanisms and explore its relevance in both basic and clinical pharmacology.
